Explore the science behind the compounds in our catalog. These summaries describe published research, including its limitations. Findings from cells or animals do not establish benefits in people, and studies of individual ingredients do not establish the effects of a blend.
Research materials sold by Elevatus Aminos are for laboratory research only, not for human or animal consumption.
EA-R3 — Retatrutide
Research focus: Metabolic signaling, body weight, and glucose regulation.
Retatrutide activates three hormone receptors: GIP, GLP-1, and glucagon. Researchers have evaluated it in controlled human clinical trials, including a published phase 2 obesity study.
Evidence limits: Clinical trials use specifically manufactured study medication under medical supervision. Their findings do not establish the safety, identity, or effectiveness of independently sold research vials.
Read the phase 2 clinical study
CJC no DAC + IPA
Research focus: Growth-hormone signaling.
Ipamorelin has been studied in human volunteers for its effects on growth-hormone release. Related CJC research has examined growth-hormone and IGF-1 responses.
Evidence limits: The frequently cited human CJC-1295 study investigated a long-acting form with DAC. It should not be treated as evidence for a no-DAC product or the specific CJC no DAC + IPA blend.
Read the ipamorelin study
Read the long-acting CJC-1295 study
GLOW — 70 mg Blend
Composition per vial:
-
GHK-Cu — 50 mg
-
BPC-157 — 10 mg
-
TB-500 — 10 mg
Research focus: The individual ingredients have been investigated in experimental models involving collagen production, cell behavior, and tissue repair.
GHK-Cu has been studied in fibroblast cultures for effects on collagen synthesis. BPC-157 has been investigated in rat tendon cells and tissue models. Research involving materials described as TB-500 includes animal tendon-repair studies.
Evidence limits: These studies do not establish cosmetic, healing, or recovery benefits in people from this exact three-ingredient blend. Study material identity also matters: findings about thymosin beta-4 or a particular fragment should not automatically be applied to every product called TB-500.
GHK-Cu cell-culture study
BPC-157 tendon-cell study
BPC-157 and TB-500 rat study
Epithalon — Also Called Epitalon
Research focus: Telomerase activity and telomere biology.
Published laboratory studies have examined Epithalon in cultured human cells, including effects on telomerase activity and telomere length.
Evidence limits: Human cells grown in a laboratory are not a human clinical trial. These findings do not demonstrate that Epithalon extends human lifespan or reverses aging.
BAC Water — 3 mL and 10 mL
BAC Water is a laboratory supply, not a peptide. Its composition, preservative content, and suitability for a particular experiment should be checked against the manufacturer’s documentation.
Compatibility depends on the research material and protocol. The product name alone does not establish compatibility or sterility.
EA-T2 — Tirzepatide
Research focus: GIP and GLP-1 receptor signaling, glucose regulation, and body weight.
Tirzepatide activates GIP and GLP-1 receptors. Researchers have evaluated it in large human clinical trials, including the SURMOUNT-1 phase 3 obesity study.
Evidence limits: Findings from clinical trials apply to the specific medication and conditions studied. They do not establish the identity, quality, or safety of independently sold research materials.
GHK-Cu
Research focus: Collagen production and extracellular-matrix biology—the structures surrounding and supporting cells.
GHK-Cu is a copper-binding tripeptide. Laboratory studies have examined its effects on collagen synthesis and matrix-related activity in fibroblasts, cells involved in connective-tissue biology.
Evidence limits: Cell-culture findings do not establish skin, hair, wound-healing, or other benefits from a research vial in people.
Read the collagen-synthesis study
KPV
Research focus: Inflammatory signaling and intestinal peptide transport.
KPV is a three-amino-acid peptide: lysine-proline-valine. Researchers have investigated its uptake through the PepT1 transporter and its effects on inflammatory pathways in cultured cells and mouse models of colitis.
Evidence limits: These experimental findings do not establish KPV as a treatment for human intestinal disease or other inflammatory conditions.
GHK-Cu/KPV Blend
Composition per vial:
-
GHK-Cu — 50 mg
-
KPV — 10 mg
Research focus: The ingredients have separate research backgrounds involving extracellular-matrix biology and inflammatory signaling.
Evidence limits: Studies of GHK-Cu or KPV individually do not establish the effects, compatibility, stability, or safety of this exact blend. Combining ingredients does not demonstrate that their effects are enhanced.
MT-1 — Melanotan I
Research focus: Melanocortin signaling and skin pigmentation.
Melanotan I is an analogue of alpha-melanocyte-stimulating hormone. Published human studies have investigated its pharmacokinetics—how it moves through the body—and changes in pigmentation.
Evidence limits: Findings from a specific study preparation do not establish the safety or effectiveness of a separately supplied research vial. Pigmentation findings should not be interpreted as proof of protection from ultraviolet damage.
Read the human pigmentation and pharmacokinetics study
MT-2 — Melanotan II
Research focus: Melanocortin-receptor activity and pigmentation.
Melanotan II is a cyclic melanocortin analogue. An early pilot phase 1 human study examined its biological effects, including pigmentation changes.
Evidence limits: A small early-phase study cannot establish long-term safety or support broad claims about tanning, sexual function, or other personal uses. MT-1 and MT-2 are different compounds; their evidence should not be treated as interchangeable.
Selank
Research focus: Anxiety-related symptoms and neuropeptide signaling.
Published research includes a small human comparative study involving 62 participants with generalized anxiety disorder or neurasthenia. Investigators assessed symptoms using psychometric scales and examined an enkephalin-related blood marker.
Evidence limits: This comparison with another medication does not provide the same evidence as a large, blinded, placebo-controlled trial. It does not establish general claims about anxiety relief, cognition, or the safety of research products.
Read the comparative human study
Vitamin B12
Research focus: Enzyme function, DNA synthesis, red-blood-cell formation, and nervous-system biology.
Vitamin B12 is a vitamin, not a peptide. Several chemical forms exist, including methylcobalamin, hydroxocobalamin, and cyanocobalamin. The specific form in a research material should be confirmed from its documentation.
Evidence limits: Established nutritional roles do not demonstrate that additional B12 improves energy or performance in people who already have adequate B12 status. Research materials are not interchangeable with approved medicines.
Read the NIH Vitamin B12 overview
NAD+ — 500 mg and 1,000 mg
Research focus: Cellular energy metabolism and NAD-related biochemical pathways.
Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme, not a peptide. A small human pilot study examined changes in blood and urine NAD-related metabolites during an intravenous infusion.
Evidence limits: Measuring metabolites does not establish benefits for longevity, fatigue, cognition, or disease treatment. Research involving NAD precursors such as NR or NMN should not automatically be applied to NAD+ itself.
Read the human metabolomics pilot study
Glutathione
Research focus: Cellular antioxidant systems and oxidative-stress biology.
Glutathione is a naturally occurring tripeptide. Human research includes a randomized trial examining whether oral supplementation changed glutathione levels in blood and other sampled cells.
Evidence limits: Results from an oral formulation do not establish the effects or safety of other formulations or routes. Changes in glutathione levels do not by themselves prove skin-lightening, “detox,” anti-aging, or disease-treatment benefits.
Read the oral supplementation trial
EA-31 — SS-31 (Elamipretide)
Research focus: Mitochondrial function and cardiolipin, a lipid in the inner mitochondrial membrane.
SS-31, also known as elamipretide, interacts with cardiolipin. Researchers have studied it in mitochondrial disorders, including Barth syndrome.
Human evidence: A small randomized Barth syndrome trial did not meet its primary walking-distance and fatigue endpoints during the placebo-controlled period. Improvements were reported during the subsequent open-label extension, which did not have a placebo comparison.
Evidence limits: Findings in a specific mitochondrial disorder do not establish general benefits for energy, athletic performance, or aging. Research vials are not interchangeable with approved elamipretide medication.
Read the Barth syndrome clinical study
Understanding the Evidence
Cell studies: Examine biological activity in laboratory-grown cells.
Animal studies: Explore effects in animal models; results may not translate to people.
Human studies: Evaluate specific preparations in defined populations. Results do not automatically apply to other formulations, blends, or research products.
This library provides scientific background, not dosing instructions, medical advice, or a recommendation for personal use.
Lipo-C Superhuman — 10 mL
Coming soon
Designed for: Exercise performance, muscle pump, energy, and recovery.
The supplier describes this blend as formulated to support nitric oxide production, workout performance, and energy, with NAC included for liver and glutathione support.
Ingredients per 10 mL:
-
L-Arginine — 110 mg
-
L-Ornithine — 110 mg
-
L-Citrulline — 120 mg
-
L-Lysine — 70 mg
-
L-Glutamine — 40 mg
-
L-Proline — 60 mg
-
L-Taurine — 60 mg
-
L-Carnitine — 220 mg
-
NAC — 75 mg
Lipo-C Focus — 10 mL
Coming soon
Designed for: Energy, mental focus, and metabolic support.
The supplier describes this blend as formulated for a stimulant-like energy and focus effect, with workout, long-shift, and fat-loss applications. L-carnitine is included for its role in fatty-acid transport.
Ingredients per 10 mL:
-
ATP — 50 mg
-
Eria Jarensis — 50 mg
-
L-Carnitine — 200 mg
-
Methionine — 25 mg
-
Inositol — 50 mg
-
Choline — 50 mg
-
Lidocaine — 0.1%
-
Benzyl Alcohol — 2%
Evidence limits: These descriptions reflect the supplier’s intended purposes, rather than proven outcomes for the finished blends. Research on individual ingredients does not establish the effects or safety of either combination.
Adamax1032 — 10 mg
Coming soon
Research information: Product-specific documentation and the certificate of analysis are pending. A description of its composition and biological activity will be added once its identity and supporting research have been verified.
AHK-Cu — 50 mg
Coming soon
Research focus: Hair-follicle biology and dermal papilla cells.
AHK-Cu is a copper complex of the tripeptide alanine–histidine–lysine. A published laboratory study reported increased elongation of isolated human hair follicles and increased proliferation of dermal papilla cells, which help regulate follicle growth.
Evidence limits: These laboratory findings do not establish hair regrowth, safety, or effectiveness in people.
Study: Pyo et al. (2007), The effect of tripeptide-copper complex on human hair growth in vitro.
https://pubmed.ncbi.nlm.nih.gov/17703734/
Product-specific analytical documentation is pending for these upcoming products.
For laboratory research only. Not for human or animal consumption.